Drugs / partially hydrolysed guar gum
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04639141 | Dec 2021 → Apr 2022 | anxiety, autism spectrum disorder | The University of Queensland | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | partially hydrolysed guar gum | “partially hydrolysed guar gum (PHGG)” NCT04639141 ↗ |
| Known as | PHGG | “partially hydrolysed guar gum (PHGG)” NCT04639141 ↗ |
| Modality | Other / unclassified | “Prebiotic + Probiotic” NCT04639141 ↗ |
| Route | Oral | “Mode of administration: oral.” NCT04639141 ↗ |